Thankyou Mr Ballsup, it's sent me down an enlightening path.
I'm attributing this research to Mr Musk and Grok."Approximately 56% of Capricorn’s 28,000 members—or about 15,680 individuals—would use Xero or MYOB accounting software.They are basing that on Xero having 50-55% marketshare and MYOB having 25-30% and roughly 30% don't use accounting software.
So based on 28,000 members that equals to 15,680
I do suppose we are all in agreeance that just because Swift isn't capable with Xero and myob now, this can't change....
but sticking with that number.
From my point of view, we can still obtain a substantial boost in our revenue.
50% = 7840 members = 9.3 million per year
40% = 6272 members = 7.4 million per year
30% = 4704 members = 5.5 million per year.
Spenda inegrates with Xero, Myob and Quickbooks, so if we assume Quicbooks (10-15% marketshare) is the next one to be added tp swift. it'll be 63%.
But I think there's only going to be an increasing push on that 30% to get digitalised and Xero are going to increase their marketshare.
Ultimately I don't know, I'll ask the question, and go off a 30% take up till then.
So that means that they have drastically over represented the numbers, and unless they know something we don't, 50% or higher over 28,000 members isn't really achieveable by September 2025. But really, I expect CEOS to drastically over represent numbers, they all name the global market size for their product.
- Forums
- ASX - By Stock
- DAILY VOLUME UPDATE
SPX
spenda limited
Add to My Watchlist
9.09%
!
0.6¢

Thankyou Mr Ballsup, it's sent me down an enlightening path.I'm...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.6¢ |
Change
0.001(9.09%) |
Mkt cap ! $27.69M |
Open | High | Low | Value | Volume |
0.6¢ | 0.7¢ | 0.6¢ | $23.32K | 3.880M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 280696 | 0.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.7¢ | 18216262 | 29 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 280696 | 0.006 |
48 | 22729523 | 0.005 |
8 | 15700000 | 0.004 |
9 | 26100000 | 0.003 |
5 | 17000002 | 0.002 |
Price($) | Vol. | No. |
---|---|---|
0.007 | 17544441 | 26 |
0.008 | 3921694 | 23 |
0.009 | 9234397 | 15 |
0.010 | 842781 | 5 |
0.011 | 527004 | 4 |
Last trade - 15.59pm 27/06/2025 (20 minute delay) ? |
Featured News
SPX (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online